Are China, Pakistan, Bangladesh quietly planting region's new framework?
South Asian Association for Regional Cooperation
For decades, SAARC was envisioned as the collective voice of South Asia, a platform where neighbours – Afghanistan, Bangladesh, Bhutan, India, the Maldives, Nepal, Pakistan and Sri Lanka – could come together despite their political differences.
Yet, SAARC today feels like a relic of a bygone era. India's
repeated refusal to participate in SAARC summits, citing tensions with Pakistan, has stalled the organisation. Even Bangladesh's recent call to revive SAARC in the post-Hasina political climate seemed more nostalgic than practical. Truth is, SAARC has always been hostage to bilateral disputes, particularly between India and Pakistan, and that structural weakness may now prove fatal.
India, unwilling to engage with Pakistan in a multilateral setting, has shifted its attention to the Bay of Bengal Initiative for Multi-Sectoral Technical and Economic Cooperation (BIMSTEC), a
seven-nation initiative – including Myanmar, Thailand, Bangladesh, Bhutan, Nepal and Sri Lanka – that notably excludes Pakistan.
Meanwhile, India's growing partnership with the United States under its
Indo-Pacific strategy has cast it as Washington's preferred regional partner in its bid to counter China's influence. This has not gone unnoticed in China, which finds itself recalibrating its South Asia engagement strategy.
For China, Pakistan is a partner in the important
China-Pakistan Economic Corridor (CPEC) and a strategic gateway to South Asia. The relationship, based on trust and deepened over the test of time, is not just convenient – it is essential. For Pakistan, which faces a gradual isolation from regional forums and remains at odds with India, an alternative multilateral framework that includes China and like-minded South Asian states could offer both strategic relevance and economic opportunity.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South China Morning Post
8 minutes ago
- South China Morning Post
Chinese bond ETFs top US$50 billion in assets managed in frenzy spurred by deflation
Chinese investors are snapping up exchange-traded funds (ETFs) that track bonds, betting on their lower costs and diversified exposure to profit from an environment of stubborn deflation and policy support for the corporate sector. Assets managed under such ETFs surged to more than US$50 billion at the end of June, up from $10 billion at the beginning of last year, according to Bloomberg data. The number of those targeting corporate notes increased sixfold since the end of last year to become the fastest-growing segment, accounting for more than half of all bond ETFs. The bond ETFs appealed to investors with cheaper costs, potentially higher returns, as well as coveted exposure to some of the country's burgeoning technology firms. They also offered better liquidity and lower default risks than investing directly in corporate debt, with some even eligible to be used as collateral for short-term borrowings. They have surged in popularity as investors hedged against an uncertain outlook for the Chinese economy, given unresolved trade frictions with the US and persistent deflationary pressures caused by weak consumption. The rapid expansion, which could stoke volatility, was driven by private funds, banks and proprietary desks at brokerages. 'Chinese investors' demand for low-risk, fixed-income assets keeps growing, so bond ETFs became an ideal candidate, given their liquidity advantage and diversified holdings,' said Rachel Sun, director of China manager research at Morningstar (Shenzhen). 'Market expansion and product innovation have provided a rich pool of underlying assets.' While China's central bank has vowed to keep monetary conditions loose, it has also repeatedly warned about risks from excessive bond rallies. With yields already near record lows, government debt was considered a crowded and less rewarding trade. In comparison, fixed-income ETFs offer investors not only capital gains but also access to higher-yielding corporate notes, which have expanded their presence in the product's underlying asset mix.
South China Morning Post
38 minutes ago
- South China Morning Post
New railway lines put Guinea and Algeria on track to send iron ore to China
China is poised to begin receiving iron ore shipments from Guinea and Algeria this year, as Chinese firms complete the railway lines and ports needed to overcome logistical bottlenecks. For years, the lack of railway infrastructure connecting mine sites to port facilities had stymied iron ore exports from both nations. These massive projects are strategically important to China as it tries to diversify its supply of iron ore away from Australia and Brazil, which together account for about 80 per cent of seaborne exports. Simandou , in the remote southeast of Guinea, is one example. It is said to have the world's largest undeveloped iron ore deposit, and to get that moving a new railway line stretching up to 650km (400 miles) to the Atlantic coast was needed. Likewise, in Algeria, there is another significant iron ore deposit at the Gara Djebilet mine deep in the southwestern Sahara Desert, near the Mauritanian border. That is about 1,650km away from Mediterranean ports – a distance that will be bridged by a combination of new and upgraded railway lines. In the remote southeast of Guinea, Simandou is said to have the world's largest undeveloped iron ore deposit. Photo: Rio Tinto In Guinea, Simandou is now on track to start shipping iron ore from November, according to Rio Tinto, the Anglo-Australian mining giant jointly developing the project with Chinese companies.
South China Morning Post
2 hours ago
- South China Morning Post
China's plan to boost drug coverage by commercial insurers no ‘magic wand', analysts say
Beijing's plan to publish China's first list of innovative drugs eligible for coverage by commercial health insurance will draw keen interest from pharmaceutical companies, but is not a 'magic wand', as insurers lack sufficient incentives to provide the coverage, analysts said. The National Healthcare Security Administration, in charge of the state-run basic healthcare insurance scheme, said in a policy document on July 1 that it would publish the list this year, primarily including drugs that were not covered by state insurance but were highly innovative and provided clear improvements in medical outcomes. The list would be a 'major attempt to better meet the public's multi-level and diverse drugs demand', said Huang Xinyu, head of the administration's medical services management department, on July 11, as reported by Xinhua. Both domestic and multinational drug developers will likely be drawn to the initiative, but the same cannot be said of insurers, said Webster Guo, principal at L.E.K. Consulting's China healthcare practice. 'There's likely no harm for drug companies to apply [to have their products included],' he said. 'If you are lagging behind your competitors, the downside could be significant.' But the situation presented an 'impossible triangle' for insurers, who would struggle to devise products that would achieve national coverage while providing sufficient reimbursement levels at a price that people were willing to pay, he said, because the source of funding was 'not solved'. Commercial health-insurance payouts of 383.8 billion yuan (US$53.5 billion) in 2023 covered only 6.8 per cent of total direct healthcare costs, while state basic health insurance covered 49.7 per cent and patients paid for 43.5 per cent themselves, according to the Shanghai Insurance Association.
